A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence

NCT00605826 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

206

Enrollment

INDUSTRY

Sponsor class

Conditions

Fecal Incontinence

Interventions

DEVICE: NASHA/Dx (Solesta) Gel
DEVICE: Sham Injection

Sponsor

Bausch Health Americas, Inc.

Collaborators

[object Object]
[object Object]